High-dose psilocybin shows promise for depression treatment

Researchers compare the effectiveness and acceptability of oral monotherapy with psychedelics for the treatment of depressive symptoms.

Medacta unveils the extended enhancements to its Hip Revision Platform – Biotech Investments

Medacta Group SA / Key word(s): Miscellaneous Medacta unveils the extended enhancements to its Hip Revision Platform 21.10.2024 / 19:00 CET/CEST MEDIA RELEASE Medacta unveils

October 22, 2024

WuXi Bio expands US presence; FujiFilm boosts autoinjector services; SpectronRx to make prostate cancer radioligand

Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls and more. WuXi Biologics is expanding its

January 12, 2024

Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Half Year Results 15.08.2023 / 09:01 CET/CEST The issuer is solely responsible for the content of this announcement.

August 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.